Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Jan 15, 2022; 14(1): 253-264
Published online Jan 15, 2022. doi: 10.4251/wjgo.v14.i1.253
Published online Jan 15, 2022. doi: 10.4251/wjgo.v14.i1.253
Figure 2 The expression of Lnc542369 and YWHAZ mRNA in vitro and in hepatocellular carcinoma patients.
A: Nuclear Lnc542369 was significantly upregulated in hepatocellular carcinoma (HCC) tissues compared with para-HCC tissues; B: YWHAZ mRNA was significantly upregulated by overexpression of Lnc542369; C: YWHAZ mRNA was significantly upregulated in HCC tissues compared with para-HCC tissues.
- Citation: Zheng W, Shen GL, Xu KY, Yin QQ, Hui TC, Zhou ZW, Xu CA, Wang SH, Wu WH, Shi LF, Pan HY. Lnc524369 promotes hepatocellular carcinoma progression and predicts poor survival by activating YWHAZ-RAF1 signaling. World J Gastrointest Oncol 2022; 14(1): 253-264
- URL: https://www.wjgnet.com/1948-5204/full/v14/i1/253.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i1.253